Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Point72 Asset Management, L.P.'s stake in Kalvista Pharmaceuticals, Inc. fell to 4.90% (Schedule 13G)
Event Jan 5, 2026 · Filed Jan 12, 2026
Point72 Asset Management, L.P.'s stake in Kalvista Pharmaceuticals, Inc. fell to 4.90%, 2,523,493 shares, as a passive investor on Jan 5, 2026. Filed Jan 12, 2026 (Schedule 13G).
- Stake
- 4.90%
- Shares
- 2,523,493
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 4.90% | 2,523,493 |
| Point72 Capital Advisors, Inc. | 4.90% | 2,523,493 |
| Steven A. Cohen | 4.90% | 2,523,493 |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Kalvista Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Jan 13, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026